Breast Cancer Clinical Trials

Showing 3981-4000 of 4,817 trials

Psycho-esthetic Impact of Tattoo Technology as Part of Mammary Reconstruction After Surgery Against Breast Cancer

NCT02464982

Mammary reconstruction replaces total skin transplant, which may causing patient discomfort. It is a simple, painless and reproductible technology that avoids consequences and complications related to transplant. Tattoo helps patients to return faster to the normal life and close more easily the cancer episode. The study purpose is to measure the patient's esthetic satisfaction degree on 1year areola tattoo realized following standard care.

Breast CancerRight or Left Breast Mammary ReconstructionMalignant Neoplasm Reconstruction by Tattoo of Areola of Female Breast

University Hospital, Strasbourg, France107 participantsStarted Feb 2012

Strasbourg, France

COMPLETEDPhase 4

Prevention of Post-Mastectomy Breast Pain Using Ambulatory Continuous Paravertebral Blocks

NCT01231204

Research study to determine if putting local anesthetic-or numbing medication-through a tiny tube placed next to the nerves that go to a breast prior to and following a mastectomy will decrease subsequent pain.

Paravertebral Catheter InsertionMastectomyBreast Cancer

University of California, San Diego60 participantsStarted Oct 2010

La Jolla, California, United States

Psycho-esthetic Impact of Tattoo Technology as Part of Mammary Reconstruction After Surgery Against Breast Cancer

Prevention of Post-Mastectomy Breast Pain Using Ambulatory Continuous Paravertebral Blocks

Related Searches

Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms

A Multicenter Breast Cancer Biospecimen Registry

Positron Emission Mammography (PEM) Biopsy Accessory for the Diagnosis of Breast Cancer

A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)

Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer

The Registration Program of BRCA1/2 Gene

Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast Cancer

A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers

Chemotherapy in Treating Patients With Breast Cancer

Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer

A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer

Phase I Combination w/ Epirubicin

Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Physical Activity, Fatigue, Sleep, and Inflammation

Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer

Efficacy and Optimal Dose Selection of Intranasal Dexmedetomidine During Breast Lumpectomy Under Local Anaesthesia

An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Breast Cancer